Enterome vs Poplar Therapeutics

Enterome vs Poplar Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Poplar Therapeutics on 51/100.

Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome
Poplar Therapeutics logo
Poplar TherapeuticsDeveloping a new class of anti-IgE therapy for multiple atopic conditions.
Try Poplar Therapeutics

Where each one leads

Enterome

  • our overall score: 60/100 against 51/100
  • domain rating: 46/100 against 4/100
  • headcount: 33 against 15
  • funding raised: $124M against $50.0M
  • LinkedIn following: 16,846 against 1,205

Poplar Therapeutics

  • agent readiness: 40/100 against 21/100

At a glance

MeasureEnteromePoplar Therapeutics
What it isClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.Developing a new class of anti-IgE therapy for multiple atopic conditions.
CategoryBiotechnology, Drug Discovery, Oncology, ImmunotherapyBiotechnology, Pharmaceuticals, HealthTech, Biotech
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformServices
Founded20122021
HeadquartersParis, FranceBoston, USA
StatusActiveActive

Size, funding and growth

MeasureEnteromePoplar Therapeutics
Employees3315
Total funding$124M$50.0M
Latest roundLater Stage VCSeries A
LinkedIn followers16,8461,205

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEnteromePoplar Therapeutics
StartupHub scoreOur 0-100 rating60/10051/100
Traction55/10051/100
Team70/10030/100
Search visibility34/10025/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (40/100)
Domain ratingLink authority, 0-10046/1004/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEnteromePoplar Therapeutics
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressWordPress
FrameworksBootstrapJquery
AnalyticsGoogle Analytics 4, SegmentGoogle Analytics 4

Enterome vs Poplar Therapeutics: common questions

Which is better, Enterome or Poplar Therapeutics?

On our 0-100 score Enterome rates higher (60/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Enterome and Poplar Therapeutics compare on the numbers?

Enterome leads on our overall score (60/100 against 51/100), domain rating (46/100 against 4/100), headcount (33 against 15), funding raised ($124M against $50.0M), LinkedIn following (16,846 against 1,205). Poplar Therapeutics leads on agent readiness (40/100 against 21/100).

Read the full Enterome review and pricing or the Poplar Therapeutics review and pricing. You can also browse other Enterome alternatives we track.